OrbiMed’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-1,722,400
| Closed | -$28.4M | – | 128 |
|
|
2018
Q3 | $28.4M | Buy |
1,722,400
+241,918
| +16% | +$3.99M | 0.34% | 76 |
|
|
2018
Q2 | $20.7M | Buy |
1,480,482
+13,682
| +0.9% | +$192K | 0.25% | 88 |
|
|
2018
Q1 | $16.2M | Sell |
1,466,800
-4,700
| -0.3% | -$51.9K | 0.2% | 87 |
|
|
2017
Q4 | $12.9M | Buy |
1,471,500
+391,800
| +36% | +$3.45M | 0.16% | 94 |
|
|
2017
Q3 | $14.4M | Hold |
1,079,700
| – | – | 0.14% | 94 |
|
|
2017
Q2 | $15.5M | Sell |
1,079,700
-4,700
| -0.4% | -$67.4K | 0.16% | 88 |
|
|
2017
Q1 | $22.9M | Buy |
1,084,400
+234,300
| +28% | +$4.96M | 0.26% | 75 |
|
|
2016
Q4 | $23.9M | Buy |
850,100
+178,500
| +27% | +$5.02M | 0.3% | 62 |
|
|
2016
Q3 | $18M | Buy |
+671,600
| New | +$18M | 0.2% | 76 |
|